<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://itamarmed.ulitzer.com"  xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Latest News from Itamar Medical News Journal</title>
 <link>http://itamarmed.ulitzer.com/</link>
 <description>Latest News from Itamar Medical News Journal</description>
 <language>en</language>
 <copyright>Copyright 2010 Ulitzer.com</copyright>
 <generator>Ulitzer.com</generator>
 <lastBuildDate>Sat, 20 Mar 2010 02:11:46 EDT</lastBuildDate>
 <docs>http://backend.userland.com/rss</docs>
 <ttl>360</ttl>
<item>
 <title>HSA Bank, UBenefit Offer Paperless Enrollment for Employers &amp; Employees</title>
 <link>http://itamarmed.ulitzer.com/node/1311290</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/1311290&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 08 Mar 2010 10:00:25 EST</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/1311290</guid>
 <comments>http://itamarmed.ulitzer.com/node/1311290#feedback</comments>
</item>
<item>
 <title>Compugen Appoints Dr. Anat Cohen-Dayag as President and CEO Martin Gerstel to Reassume Chairman Post</title>
 <link>http://itamarmed.ulitzer.com/node/1303517</link>
 <description>&lt;p&gt;
      Compugen (NASDAQ:CGEN) announced today the appointment of Anat 
      Cohen-Dayag, Ph.D. as president and CEO, and Martin Gerstel as chairman. 
      Previously, Dr. Cohen-Dayag and Mr. Gerstel served as co-CEOs of the 
      company.
    &lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/1303517&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Tue, 02 Mar 2010 07:07:07 EST</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/1303517</guid>
 <comments>http://itamarmed.ulitzer.com/node/1303517#feedback</comments>
</item>
<item>
 <title>Turkey&#039;s Social Security Institution Adopts Attunity CDC to Enable Real-time Business Intelligence and Data Warehousing</title>
 <link>http://itamarmed.ulitzer.com/node/1268733</link>
 <description>Attunity
Ltd. (OTC BB: ATTUF.OB), a leading provider of real-time data integration and
event capture software, announced today that its Attunity Stream product,
with real-time and low-impact CDC technology, has been adopted by the Turkish
government&#039;s Social Security Institution (SGK), serving 60 million people, to
enable the delivery of timely and integrated information required for
improving customer service, enhancing employee productivity and increasing
business process efficiencies.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/1268733&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Tue, 02 Feb 2010 07:00:35 EST</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/1268733</guid>
 <comments>http://itamarmed.ulitzer.com/node/1268733#feedback</comments>
</item>
<item>
 <title>RVU™ Technology on Display at CES2010</title>
 <link>http://itamarmed.ulitzer.com/node/1236389</link>
 <description>&lt;p&gt;
      The RVU Alliance announced today that Airgain, Broadcom, Entropic, 
      Samsung, STMicroelectronics and Zoran will be demonstrating the 
      pixel-accurate RVU Remote User Interface (RUI) technology at CES 2010.
    &lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/1236389&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Tue, 05 Jan 2010 15:17:38 EST</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/1236389</guid>
 <comments>http://itamarmed.ulitzer.com/node/1236389#feedback</comments>
</item>
<item>
 <title>Attunity Partners with Open Text</title>
 <link>http://itamarmed.ulitzer.com/node/1227444</link>
 <description>Attunity Ltd. announced today that it has partnered with Open Text Corporation, an enterprise software company and a leader in enterprise content management, who will market advanced data connectivity solutions, including legacy decommissioning, data lifecycle management and real-time data warehousing, which will leverage Attunity&#039;s legacy data connectivity and low-impact change data capture (CDC) technology.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/1227444&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 21 Dec 2009 07:00:00 EST</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/1227444</guid>
 <comments>http://itamarmed.ulitzer.com/node/1227444#feedback</comments>
</item>
<item>
 <title>Atlantic Detroit Diesel-Allison Adopts Attunity&#039;s Real-Time Operational Data Replication (ODR) Solution</title>
 <link>http://itamarmed.ulitzer.com/node/1191942</link>
 <description>Attunity
Ltd. (OTC BB: ATTUF.OB), a leading provider of real-time data integration and
event capture software, announced today that Atlantic Detroit Diesel-Allison
(Atlantic DDA), an on-highway and off-highway products distributor, selected
its real-time Operational Data Replication (ODR) solution and low-impact CDC
technology to enable it to double its repair order capacity and associated
revenues. According to Atlantic DDA, the implementation of Attunity&#039;s
solution has also improved overall efficiency of its service department
operations and customer satisfaction by enabling better response time and the
ability to provide the most up-to-date information to customers.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/1191942&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Wed, 18 Nov 2009 07:00:38 EST</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/1191942</guid>
 <comments>http://itamarmed.ulitzer.com/node/1191942#feedback</comments>
</item>
<item>
 <title>Attunity Extends its Partnership with Microsoft to Enable Heterogeneous Change Data Capture</title>
 <link>http://itamarmed.ulitzer.com/node/1167643</link>
 <description>Attunity
Ltd. (OTC BB: ATTUF.OB), a leading provider of real-time data integration and
event capture software, announced today a strategic partnership to market
solutions that enable real-time business intelligence and efficient data
integration based on the companies&#039; data integration products. The solution,
based on Microsoft&#039;s SQL Server Integration Services (SSIS) and Attunity&#039;s
low-impact change data capture (CDC) technology, enables efficient and
real-time integration of heterogeneous data with significant cost savings.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/1167643&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 02 Nov 2009 07:00:00 EST</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/1167643</guid>
 <comments>http://itamarmed.ulitzer.com/node/1167643#feedback</comments>
</item>
<item>
 <title>Attunity Introduces Suite of Operational Data Replication (ODR) Solutions Integrated With Microsoft SQL Server Integration Services (SSIS)</title>
 <link>http://itamarmed.ulitzer.com/node/1161116</link>
 <description>Attunity
Ltd. (OTC BB: ATTUF.OB), a leading provider of real-time data integration and
event capture software, introduced today a suite of Operational Data
Replication (ODR) solutions integrated with Microsoft SQL Server Integration
Services (SSIS) which is designed to enable customers to replicate data in
real-time across a set of heterogeneous data sources at an affordable price
point. The solutions, which are designed to enhance business intelligence
(BI), improve business operations and reduce total costs, will be presented
at PASS Summit 2009, November 2-4, at the Washington State Convention &amp; Trade
Center in Seattle, WA.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/1161116&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Tue, 27 Oct 2009 14:00:31 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/1161116</guid>
 <comments>http://itamarmed.ulitzer.com/node/1161116#feedback</comments>
</item>
<item>
 <title>Yissum Announces Long-Term Multi-Project Research and License Collaboration with Roche</title>
 <link>http://itamarmed.ulitzer.com/node/1155043</link>
 <description>&lt;p&gt;
      Yissum Research Development Company of the Hebrew University of 
      Jerusalem Ltd., the technology transfer arm of the University, today 
      announced that it has signed a long-term multi-project research and 
      license collaboration agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY).
    &lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/1155043&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Thu, 22 Oct 2009 09:21:54 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/1155043</guid>
 <comments>http://itamarmed.ulitzer.com/node/1155043#feedback</comments>
</item>
<item>
 <title>Macau Government Agency Adopts Attunity&#039;s Real-Time Operational Data Replication (ODR) Solution</title>
 <link>http://itamarmed.ulitzer.com/node/1150468</link>
 <description>Attunity
Ltd. (OTC BB: ATTUF), a leading provider of real-time data integration and
event capture software, announced today that its real-time operational data
replication (ODR) software and low-impact CDC technology has been adopted by
the Macau Government&#039;s Civic and Municipal Affairs Bureau (also known as
IACM) in order to improve customer service quality and responsiveness for the
Macau community, work more efficiently with other government agencies and
save significant time and money on capital and human resources.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/1150468&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Tue, 20 Oct 2009 07:00:58 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/1150468</guid>
 <comments>http://itamarmed.ulitzer.com/node/1150468#feedback</comments>
</item>
<item>
 <title>Attunity Introduces ODR Solutions for Oracle Customers</title>
 <link>http://itamarmed.ulitzer.com/node/1140162</link>
 <description>Attunity Ltd., introduces today a set of solutions based on a new concept coined &#039;Operational Data Replication&#039; (ODR), which is designed to enable the large market of Oracle customers to replicate data in real-time to and from Oracle databases, at an affordable price point.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/1140162&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 12 Oct 2009 07:00:00 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/1140162</guid>
 <comments>http://itamarmed.ulitzer.com/node/1140162#feedback</comments>
</item>
<item>
 <title>Prominent Hedge Fund Adopts Attunity&#039;s Change Data Capture (CDC) for SSIS Solution to Enable Trading and Reporting in Real Time</title>
 <link>http://itamarmed.ulitzer.com/node/1127809</link>
 <description>Attunity
Ltd. (OTC BB: ATTUF.OB), a leading provider of real-time data integration and
event capture software, announced today that a prominent, privately-held
hedge fund firm based in the US has selected Attunity&#039;s Change Data Capture
(CDC) for SSIS solution to enable access to the hedge fund&#039;s trading and
reporting databases in real time, streamline their business and improve
operations and business intelligence (BI). According to the hedge fund firm,
Attunity&#039;s non-intrusive CDC technology enabled it to quadruple their
standard trade volume and extended $10 million in additional business
opportunity.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/1127809&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Thu, 01 Oct 2009 07:00:27 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/1127809</guid>
 <comments>http://itamarmed.ulitzer.com/node/1127809#feedback</comments>
</item>
<item>
 <title>Glenridge Solutions Partners With Attunity to Enhance Data Warehouse Appliance Solution With Real-Time Data Integration</title>
 <link>http://itamarmed.ulitzer.com/node/1106522</link>
 <description>Attunity Ltd. (OTC BB: ATTUF.OB), a leading
provider of real-time data integration and event capture software, and
Glenridge Solutions LLC, a provider of end-to-end data warehouse solutions,
announced today a partnership that extends the value of Glenridge Solutions&#039;
rapidly configurable data warehouse with the power of Attunity&#039;s real-time
data integration based on non-intrusive Change-Data-Capture (CDC) technology.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/1106522&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Tue, 15 Sep 2009 07:00:44 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/1106522</guid>
 <comments>http://itamarmed.ulitzer.com/node/1106522#feedback</comments>
</item>
<item>
 <title>Attunity Recognized for Excellence With 2009 Readers&#039; Choice Award From Visual Studio Magazine</title>
 <link>http://itamarmed.ulitzer.com/node/1057018</link>
 <description>Attunity,
Ltd. (OTC BB: ATTUF.OB), a leading provider of real-time data integration,
replication and event-capture software, announced that Attunity Oracle-CDC
for SSIS is honored with a Readers&#039; Choice Merit Award in the product
category of Middleware &amp; Server-Based Tools from Visual Studio Magazine. The
2009 winners, which will appear in the August issue, are chosen by Visual
Studio Magazine&#039;s readers and honor excellent software in key development
categories.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/1057018&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 03 Aug 2009 07:01:30 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/1057018</guid>
 <comments>http://itamarmed.ulitzer.com/node/1057018#feedback</comments>
</item>
<item>
 <title>Compugen Appoints Dr. Anat Cohen-Dayag and Martin Gerstel as Co-CEOs</title>
 <link>http://itamarmed.ulitzer.com/node/985369</link>
 <description>&lt;p&gt;
      Compugen (NASDAQ:CGEN) announced today the appointment of Anat 
      Cohen-Dayag, Ph.D. and Martin Gerstel as co-CEOs of the company.
    &lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/985369&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Tue, 02 Jun 2009 06:09:49 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/985369</guid>
 <comments>http://itamarmed.ulitzer.com/node/985369#feedback</comments>
</item>
<item>
 <title>Attunity Introduces Real-Time Integration of Oracle Data With SQL Server Integration Services</title>
 <link>http://itamarmed.ulitzer.com/node/978199</link>
 <description>Attunity,
Ltd. (OTC BB: ATTUF.OB), a leading provider of real-time data integration and
event capture software, announced today the general availability (GA) of
Attunity Oracle-CDC for SSIS, delivering market leading change data capture
(CDC) technology tightly-integrated with Microsoft SQL Server Integration
Services (SSIS) that makes integration, replication, and synchronization of
Oracle data efficient, real-time, and affordable.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/978199&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Wed, 27 May 2009 09:12:00 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/978199</guid>
 <comments>http://itamarmed.ulitzer.com/node/978199#feedback</comments>
</item>
<item>
 <title>Attunity Delivers Real-time Change Data Capture for Anadolu Sigorta, a Leading Premium Insurance Provider in Turkey</title>
 <link>http://itamarmed.ulitzer.com/node/969011</link>
 <description>Attunity, Ltd.
(OTC: ATTUF), a leading provider of real-time event capture and data
integration software, announced today that Anadolu Anonim Turk Sigorta
Sirketi had selected Attunity&#039;s Integration Suite (AIS) to deliver
up-to-the-minute information for its 1500 insurance agents and branches
across Turkey.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/969011&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Tue, 19 May 2009 09:01:29 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/969011</guid>
 <comments>http://itamarmed.ulitzer.com/node/969011#feedback</comments>
</item>
<item>
 <title>Mayo Study Shows Simple Finger Device May Help Predict Future Heart Events, Such as Heart Attack</title>
 <link>http://itamarmed.ulitzer.com/node/894485</link>
 <description>Results of a Mayo Clinic study show that a simple, noninvasive finger sensor test is &quot;highly predictive&quot; of a major cardiac event, such as a heart attack or stroke, for people who are considered at low or moderate risk, according to researchers.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/894485&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Thu, 26 Mar 2009 14:28:59 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/894485</guid>
 <comments>http://itamarmed.ulitzer.com/node/894485#feedback</comments>
</item>
<item>
 <title>ECA disipa los rumores de la &#039;Super Liga&#039;</title>
 <link>http://itamarmed.ulitzer.com/node/882304</link>
 <description>El comité ejecutivo de la ECA, reunido en Ámsterdam para su reunión
regular, quiere disipar el contenido de los artículos publicados hoy en
algunos de los principales periódicos deportivos de Europa. Estos artículos
mencionan planes para una futura &quot;Super Liga&quot;.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/882304&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Wed, 18 Mar 2009 05:46:40 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/882304</guid>
 <comments>http://itamarmed.ulitzer.com/node/882304#feedback</comments>
</item>
<item>
 <title>L&#039;ECA (Association des Clubs Européens) dément les rumeurs de &lt;&lt; Super Ligue &gt;&gt;</title>
 <link>http://itamarmed.ulitzer.com/node/882302</link>
 <description>Le Conseil d&#039;Administration de l&#039;ECA, rassemblé à Amsterdam lors de sa
traditionnelle réunion, veut démentir le contenu des articles publiés
aujourd&#039;hui dans certains des plus grands journaux sportifs européens. Ils
parlent en effet de projets concernant une prochaine &lt;&lt; Super Ligue &gt;&gt;.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/882302&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Wed, 18 Mar 2009 05:42:55 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/882302</guid>
 <comments>http://itamarmed.ulitzer.com/node/882302#feedback</comments>
</item>
<item>
 <title>ECA Dismisses &#039;Super League&#039; Rumours</title>
 <link>http://itamarmed.ulitzer.com/node/881566</link>
 <description>The ECA Executive Board, assembled in Amsterdam for its regular meeting,
wants to dismiss the content of articles published today in some of the major
sports newspapers in Europe. These articles mention plans for a future &quot;Super
League&quot;.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/881566&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Tue, 17 Mar 2009 14:02:25 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/881566</guid>
 <comments>http://itamarmed.ulitzer.com/node/881566#feedback</comments>
</item>
<item>
 <title>BioMarin Uses Itamar Medical&#039;s Endo-PAT2000 In Successful Phase 2 Study For New Treatment For Sickle Cell Disease</title>
 <link>http://itamarmed.ulitzer.com/node/853920</link>
 <description>Itamar Medical announced the use of the company&#039;s patented Endo-PAT2000 in BioMarin Pharmaceutical Inc.&#039;s phase 2 study of patients with Sickle Cell Disease (SCD). The Endo-PAT2000 was used to measure endothelial function in a study designed to evaluate whether the drug 6R-BH4 can improve endothelial function in SCD patients.  &lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/853920&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Wed, 25 Feb 2009 04:30:00 EST</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/853920</guid>
 <comments>http://itamarmed.ulitzer.com/node/853920#feedback</comments>
</item>
<item>
 <title>Itamar Medical&#039;s Endo-PAT2000 Approved For Use by Australian Government&#039;s TGA </title>
 <link>http://itamarmed.ulitzer.com/node/853919</link>
 <description>Itamar Medical announced that it has received TGA clearance for the Endo-PAT2000, certifying the Endo-PAT2000 for use and distribution in Australia. Itamar Medical has developed the first simple, inexpensive, office-based diagnostic test for endothelial function. The Endo-PAT2000 is a noninvasive device that measures endothelial function, the earliest clinically detectable stage of cardiovascular disease, using bio-sensors mounted on patients’ fingers that measure minute changes in vascular tone using Itamar Medical&#039;s PAT Signal technology.

 &lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/853919&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Wed, 25 Feb 2009 04:26:00 EST</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/853919</guid>
 <comments>http://itamarmed.ulitzer.com/node/853919#feedback</comments>
</item>
<item>
 <title>Itamar Medical&#039;s Endo-PAT2000 Now Available in Italy </title>
 <link>http://itamarmed.ulitzer.com/node/853918</link>
 <description>Itamar Medical announced its distribution agreement with EndoTech SPA to bring Itamar Medical&#039;s patented Endo-PAT2000,  the first simple, office-based diagnostic test for the assessment of endothelial function, to the Italian market.
&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/853918&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Wed, 25 Feb 2009 04:19:00 EST</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/853918</guid>
 <comments>http://itamarmed.ulitzer.com/node/853918#feedback</comments>
</item>
<item>
 <title>Flavonoids Can Prevent Impairment of Endothelial Function After High-Fat Meals </title>
 <link>http://itamarmed.ulitzer.com/node/847681</link>
 <description>In the results of a new clinical study published by the Oxford Journal of Evidence-Based Complementary and Alternative Medicine, researchers find that supplementing your diet with flavonoids can reduce the acute decline in endothelial function caused by eating a high-fat meal. 
&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/847681&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Thu, 19 Feb 2009 08:00:00 EST</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/847681</guid>
 <comments>http://itamarmed.ulitzer.com/node/847681#feedback</comments>
</item>
<item>
 <title>Dr. Dov Rubin zum Chief Executive Officer von Itamar Medical ernannt</title>
 <link>http://itamarmed.ulitzer.com/node/757046</link>
 <description>&lt;p&gt;
      Itamar Medical hat die Ernennung von Dr. Dov Rubin zum Chief Executive 
      Officer des Unternehmens bekannt gegeben. Dr. Rubin übernimmt damit den 
      Posten von Israel Schreiber.
    &lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/757046&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Fri, 21 Nov 2008 01:47:18 EST</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/757046</guid>
 <comments>http://itamarmed.ulitzer.com/node/757046#feedback</comments>
</item>
<item>
 <title>Le Dr Dov Rubin nommé président-directeur général d’Itamar Medical</title>
 <link>http://itamarmed.ulitzer.com/node/756492</link>
 <description>&lt;p&gt;
      Itamar Medical a annoncé la nomination du Dr Dov Rubin au poste de 
      président-directeur général. Dov prendra la succession d’Israel 
      Schreiber.
    &lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/756492&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Thu, 20 Nov 2008 12:58:24 EST</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/756492</guid>
 <comments>http://itamarmed.ulitzer.com/node/756492#feedback</comments>
</item>
<item>
 <title>Dr. Dov Rubin Appointed Chief Executive Officer of Itamar Medical</title>
 <link>http://itamarmed.ulitzer.com/node/755683</link>
 <description>&lt;p&gt;
      Itamar Medical has announced the appointment of Dr. Dov Rubin as its 
      Chief Executive Officer. Dov will be following Israel Schreiber.
    &lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/755683&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Thu, 20 Nov 2008 06:53:20 EST</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/755683</guid>
 <comments>http://itamarmed.ulitzer.com/node/755683#feedback</comments>
</item>
<item>
 <title>Compugen Appoints Martin Gerstel CEO Effective January 2009</title>
 <link>http://itamarmed.ulitzer.com/node/744723</link>
 <description>&lt;p&gt;
      Compugen Ltd. (NASDAQ: &lt;a href=&quot;http://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fquote.yahoo.com%2Fq%3Fs%3Dcgen%26d%3Dt&amp;amp;esheet=5829114&amp;amp;lan=en_US&amp;amp;anchor=CGEN&amp;amp;index=1&quot;&gt;CGEN&lt;/a&gt;) 
      announced today the appointment of Mr. Martin Gerstel as president and 
      chief executive officer, effective January 1, 2009. Mr. Gerstel, who has 
      served as chairman of Compugen since 1997, will succeed current 
      president and chief executive officer Mr. Alex Kotzer, who recently 
      informed the Board of his interest to retire from his full time 
      executive responsibilities. Mr. Kotzer will remain a director of the 
      Company.
    &lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/744723&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Wed, 12 Nov 2008 02:00:44 EST</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/744723</guid>
 <comments>http://itamarmed.ulitzer.com/node/744723#feedback</comments>
</item>
<item>
 <title>Twofish Expands Team and Technology to Meet Growing Need to Monetize the Social Web</title>
 <link>http://itamarmed.ulitzer.com/node/706193</link>
 <description>&lt;p&gt;
      &lt;a href=&quot;http://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.twofish.com&amp;amp;esheet=5800651&amp;amp;lan=en_US&amp;amp;anchor=Twofish%2C+Inc&amp;amp;index=1&quot;&gt;Twofish, 
      Inc&lt;/a&gt;. announced today that it has secured a second round of funding 
      to build out its exclusive &lt;a href=&quot;http://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.twofish.com%2Fwhy_twofish.html&amp;amp;esheet=5800651&amp;amp;lan=en_US&amp;amp;anchor=Digital+Resource+Planning+%28DRP%29&amp;amp;index=1&quot;&gt;Digital 
      Resource Planning (DRP)&lt;/a&gt; solution, &lt;a href=&quot;http://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.twofish.com%2Felements.html&amp;amp;esheet=5800651&amp;amp;lan=en_US&amp;amp;anchor=Twofish+Elements%E2%84%A2&amp;amp;index=1&quot;&gt;Twofish 
      Elements&lt;span id=&quot;bwanpa2&quot;&gt;™&lt;/span&gt;&lt;/a&gt;. Elements is an economic 
      infrastructure that unifies banking, inventory and commerce systems of 
      online entertainment companies, allowing them to increase profits, 
      better engage customers, and reduce fraud.
    &lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/706193&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Fri, 10 Oct 2008 11:00:46 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/706193</guid>
 <comments>http://itamarmed.ulitzer.com/node/706193#feedback</comments>
</item>
<item>
 <title>Examine the World Cardiovascular Disease Diagnostics Markets</title>
 <link>http://itamarmed.ulitzer.com/node/558717</link>
 <description>Reportlinker.com announces that a new market research report related to the Cardiovascular diseases industry is available in its catalogue.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/558717&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 05 May 2008 12:02:00 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/558717</guid>
 <comments>http://itamarmed.ulitzer.com/node/558717#feedback</comments>
</item>
<item>
 <title>WikiAnswers.com Teams with Itamar Medical, Leveraging Online Social Knowledge Platform for Q&amp;A category on Cardiovascular Health</title>
 <link>http://itamarmed.ulitzer.com/node/520830</link>
 <description>In an effort to facilitate the process whereby patients receive the most up-to-date information, Answers Corp. and Itamar Medical will use the WikiAnswers Social Knowledge community platform for facilitating more efficient dialogue between doctors and patients. The companies will leverage the power of the Internet as a global knowledge repository where user-generated content and Social Knowledge groups are among the fastest growing phenomena. 

&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/520830&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 17 Mar 2008 16:28:00 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/520830</guid>
 <comments>http://itamarmed.ulitzer.com/node/520830#feedback</comments>
</item>
<item>
 <title>Generex Biotechnology to Present Clinical Data at the 9th Annual Canadian Diabetes Association / Canadian Society of Endocrinology and Metabolism Professional Conference and Annual Meetings</title>
 <link>http://itamarmed.ulitzer.com/node/143676</link>
 <description>Generex Biotechnology Corporation (NASDAQ: GNBT), aleader in the area of buccal drug delivery, today announced that theCompany will make three poster presentations of Oral-lyn&amp;#153; clinical data onbehalf of the Company at the 9th Annual Canadian Diabetes Association /Canadian Society of Endocrinology and Metabolism Professional Conferenceand Annual Meetings to be held in Edmonton, Alberta, from October 20 - 22,2005.  The three presentations are as follows:&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/143676&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Thu, 20 Oct 2005 13:00:00 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/143676</guid>
 <comments>http://itamarmed.ulitzer.com/node/143676#feedback</comments>
</item>
<item>
 <title>HSA Bank Announces Online Enrollment Capability</title>
 <link>http://itamarmed.ulitzer.com/node/81542</link>
 <description>HSA Bank(TM), a division of Webster Bank, N.A., a subsidiary of Webster Financial Corporation , has launched an online enrollment feature on its website: &lt;a href=&quot;http://www.hsabank.com/&quot; title=&quot;http://www.hsabank.com/&quot;&gt;http://www.hsabank.com/&lt;/a&gt; .  The feature enables prospective accountholders to complete and submit health savings account (HSA) applications on the Internet.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/81542&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 02 May 2005 18:35:00 EDT</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/81542</guid>
 <comments>http://itamarmed.ulitzer.com/node/81542#feedback</comments>
</item>
<item>
 <title>HSA Bank Launches Enhanced Website</title>
 <link>http://itamarmed.ulitzer.com/node/75327</link>
 <description>HSA Bank, a division of Webster Bank, N.A., has launched an enhanced website featuring easier navigation, a new &#039;employers&#039; section and a more detailed agent login area.&lt;p&gt;&lt;a href=&quot;http://itamarmed.ulitzer.com/node/75327&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Tue, 22 Mar 2005 14:30:00 EST</pubDate>
 <guid isPermaLink="true">http://itamarmed.ulitzer.com/node/75327</guid>
 <comments>http://itamarmed.ulitzer.com/node/75327#feedback</comments>
</item>
</channel>
</rss>

